Combination therapy comprising romidepsin and I.A. bortezomib

Details for Australian Patent Application No. 2008209555 (hide)

Owner Gloucester Pharmaceuticals, Inc.

Inventors Grant, Steven; Keegan, Mitchell

Agent Pizzeys

Pub. Number AU-A-2008209555

PCT Pub. Number WO2008/091620

Priority 61/005,774 07.12.07 US; 60/886,169 23.01.07 US

Filing date 23 January 2008

Wipo publication date 31 July 2008

International Classifications

A61K 31/69 (2006.01) - Boron compounds

A61K 38/15 (2006.01) Medicinal preparations containing peptides - Depsipeptides

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/091620 Priority application(s): WO2008/091620

3 September 2009 Amendment Made

  The nature of the amendment is: Add the coapplicant Virginia Commonwealth University

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008209561-Apparatus for high throughput chemical reactions

2008209543-Stabilized sulforaphane